Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

Share Price is delayed by 15 minutes
Get Live Data
72.50    0.00 (0.00%)
Bid:
72.40
Ask:
72.80
Spread: 0.40 (0.552%)
Market Cap: €11.59b
KYGA Live PriceLast checked at - London Stock Exchange

Intraday Kerry Share Chart

Kerry Increases its Stake in Proparent B.V.

7 Oct 2022 07:00

RNS Number : 0863C
Kerry Group PLC
07 October 2022
 

 

 

7 October 2022

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP

Kerry Increases its Stake in Proparent B.V. (Owner of Ojah B.V.)

Kerry Group plc ("Kerry"), the global taste & nutrition company, today announces that it has reached agreement to increase its joint venture stake in Proparent B.V. ("Proparent"), which is the 100% owner of Ojah B.V. ("Ojah") - the Dutch manufacturer of texturised plant-based proteins. Having initially purchased a 55% stake in 2018, Kerry will increase its holding to 75% for an incremental consideration of €20m in line with terms agreed at the time of the initial investment. Thomas Ahlinder, President & CEO Kerry Europe commented "The partnership with Ojah has delivered excellent growth thanks to its high-quality offering. Kerry has unique expertise in addressing the multitude of complexities in delivering taste, nutrition, and functionality combined with sustainable plant protein substrates, thereby supporting our customers in providing differentiated solutions that address the needs of a dynamic consumer base".

Acquisitions are an important part of Kerry's strategy. In order to give further insight and context for its acquisitions, Kerry is providing additional information in relation to the acquisitions that it completes including, stating for each acquisition whether equity or assets were acquired and the strategic rationale for the acquisition. Included also is the percentage of voting equity acquired in the case of an equity acquisition, and the business unit/line acquired in the case of an asset acquisition. A table setting out this information in relation to the acquisitions made by Kerry in the period 2011 to 2022 year to date is available on Kerry's website under the financial highlights section on kerry.com/investors.

 

 

ENDS

 

 

CONTACT INFORMATION

 

Investor Relations

Marguerite Larkin, Chief Financial Officer

+353 66 7182292 | investorrelations@kerry.ie

 

 

William Lynch, Head of Investor Relations

+353 66 7182292 | investorrelations@kerry.ie

 

Media

 

Catherine Keogh, Chief Corporate Affairs & Brand Officer

 

+353 45 930188 | corpaffairs@kerry.com

Website

 

www.kerry.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
JVEUPGGWUUPPGQQ
Date   Source Headline
2nd Jun 20269:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
22nd May 20266:04 pmRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:07 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20264:58 pmRNSResult of AGM
30th Apr 20267:00 amRNSQ1 Interim Management Statement 2026
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20262:40 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 202611:13 amRNSNotice of 2026 AGM
24th Mar 20263:36 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 202611:00 amRNSAnnual Financial Report
16th Mar 20261:33 pmRNSIssuance of Equity Securities
16th Mar 20261:33 pmRNSIssuance of Equity Securities
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20261:16 pmRNSDirector/PDMR Shareholding
4th Mar 20261:14 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20268:23 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20265:06 pmRNSDirector/PDMR Shareholding
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202610:13 amRNSDirector/PDMR Shareholding
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20263:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.